CNBC
US · 4 hrs ago
✦ 78◉ Centre
Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas
78Quality
0Ratings
0Comments
AI Analysis
Quality 78/100
Partisan intensity 25/100
ObjectivePartisan
◉ Centre ✓ Fair headline
Eli Lilly's chief dealmaker signals the company's willingness to pursue acquisitions in new therapeutic areas now that it has become the world's most valuable pharmaceutical company.
Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas
Eli Lilly's new top dealmaker explains how the company changed its approach to M&A now that it's the most valuable pharmaceutical company in the world.
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!